Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Vaccines
Study results from St. George's University provide new insights into HIV/AIDS vaccines
December 3rd, 2008
Fresh data on HIV/AIDS are presented in the report 'HIV immunopathogenesis and strategies for intervention.' "Therapeutic options aimed at tackling the HIV pandemic face many obstacles. The lack of readily accessible and affordable therapies means that most of those affected go untreated," scientists in London, the United Kingdom report. "The array of escape mechanisms used by HIV has undermined the efficiency of many antiviral products and continually represents a barrier to the development of an effective vaccine. Recent developments have seen a shift away from a cytopathic viral model of HIV pathogenesis towards the crucial role of immunopathogenic features--notably...
Source: Vaccine Weekly (2008-12-03)
|
